# Vaginal Biorevitalization With Polydeoxyribonucleotides for the Improvement of the Genitourinary Syndrome of Menopause

> **NCT05464654** · NA · COMPLETED · sponsor: **Hospital Regional 1o de Octubre** · enrollment: 136 (actual)

## Conditions studied

- Genitourinary Syndrome of Menopause
- Postmenopausal Disorder
- Menopause
- Vagina Atrophy

## Interventions

- **DRUG:** 3 g Polynucleotide vaginal suppositories
- **DRUG:** Conjugated estrogens cream 1g Tube

## Key facts

- **NCT ID:** NCT05464654
- **Lead sponsor:** Hospital Regional 1o de Octubre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-23
- **Primary completion:** 2021-11-23
- **Final completion:** 2022-12-31
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2023-04-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05464654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05464654, "Vaginal Biorevitalization With Polydeoxyribonucleotides for the Improvement of the Genitourinary Syndrome of Menopause". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05464654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*